Neuronal-derived extracellular vesicles are enriched in the brain and serum of HIV-1 transgenic rats

References

• Ko A, Kang G, Hattler JB, et al. Macrophages but not astrocytes harbor HIV DNA in the brains of HIV-1-Infected aviremic individuals on suppressive antiretroviral therapy. J Neuroimmune Pharmacol. 2019;14:110–11.
   Web of Science ®Google Scholar
• Heaton RK, Clifford DB, Franklin DR Jr., et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology. 2010;75:2087–2096.
   PubMed Web of Science ®Google Scholar
• Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis. 2002;186(Suppl 2):S193–198.
   PubMed Web of Science ®Google Scholar
• Mediouni S, Darque A, Baillat G, et al. Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein. Infect Disord Drug Targets. 2012;12:81–86.
   PubMedGoogle Scholar
• Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3–16.
   PubMed Web of Science ®Google Scholar
• Chan P, Hellmuth J, Spudich S, et al. Cognitive impairment and persistent CNS injury in treated HIV. Curr HIV/AIDS Rep. 2016;13:209–217.
   Web of Science ®Google Scholar
• Eggers C, Arendt G, Hahn K, et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol. 2017;264:1715–1727.
   PubMed Web of Science ®Google Scholar
• Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis. 2013;13:976–986.
   PubMed Web of Science ®Google Scholar
• Hu G, Yang L, Cai Y, et al. Emerging roles of extracellular vesicles in neurodegenerative disorders: focus on HIV-associated neurological complications. Cell Death Dis. 2016;7:e2481.
   PubMed Web of Science ®Google Scholar
• Quek C, Hill AF. The role of extracellular vesicles in neurodegenerative diseases. Biochem Biophys Res Commun. 2017;483:1178–1186.
   Web of Science ®Google Scholar
• Buschmann D, Kirchner B, Hermann S, et al. Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing. J Extracell Vesicles. 2018;7:1481321.
   PubMed Web of Science ®Google Scholar
• Izadpanah M, Seddigh A, Ebrahimi Barough S, et al. Potential of extracellular vesicles in neurodegenerative diseases: diagnostic and therapeutic indications. J Mol Neurosci. 2018;66:172–179.
   Web of Science ®Google Scholar
• Fruhbeis C, Frohlich D, Kramer-Albers EM. Emerging roles of exosomes in neuron-glia communication. Front Physiol. 2012;3:119.
   PubMed Web of Science ®Google Scholar
• Hu G, Liao K, Niu F, et al. Astrocyte EV-Induced lincRNA-Cox2 regulates microglial phagocytosis: implications for morphine-mediated neurodegeneration. Mol Ther Nucleic Acids. 2018;13:450–463.
   Google Scholar
• Chaudhuri AD, Dastgheyb RM, Yoo SW, et al. TNFalpha and IL-1beta modify the miRNA cargo of astrocyte shed extracellular vesicles to regulate neurotrophic signaling in neurons. Cell Death Dis. 2018;9:363.
   Web of Science ®Google Scholar
• Schwab A, Meyering SS, Lepene B, et al. Extracellular vesicles from infected cells: potential for direct pathogenesis. Front Microbiol. 2015;6:1132.
   PubMed Web of Science ®Google Scholar
• Hu G, Gong AY, Roth AL, et al. Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. PLoS Pathog. 2013;9:e1003261.
   Web of Science ®Google Scholar
• Hu G, Drescher KM, Chen XM. Exosomal miRNAs: biological properties and therapeutic potential. Front Genet. 2012;3:56.
   PubMedGoogle Scholar
• Shi M, Sheng L, Stewart T, et al. New windows into the brain: central nervous system-derived extracellular vesicles in blood. Prog Neurobiol. 2019;175:96–106.
   PubMed Web of Science ®Google Scholar
• Schiera G, Di Liegro CM, Di Liegro I. Extracellular membrane vesicles as vehicles for brain cell-to-cell interactions in physiological as well as pathological conditions. Biomed Res Int. 2015;2015:152926.
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341–345.
   PubMed Web of Science ®Google Scholar
• Liao K, Niu F, Dagur RS, et al. Intranasal delivery of lincRNA-Cox2 siRNA loaded extracellular vesicles decreases lipopolysaccharide-induced microglial proliferation in mice. J Neuroimmune Pharmacol. 2019. https://doi.org/10.1007/s11481-019-09864-z
   Web of Science ®Google Scholar
• Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011;19:1769–1779.
   PubMed Web of Science ®Google Scholar
• Gamez-Valero A, Beyer K, Borras FE. Extracellular vesicles, new actors in the search for biomarkers of dementias. Neurobiol Aging. 2019;74:15–20.
   Web of Science ®Google Scholar
• Pulliam L, Sun B, Mustapic M, et al. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer’s disease. J Neurovirol. 2019;25:702–709.
   PubMed Web of Science ®Google Scholar
• Rathjen FG, Schachner M. Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion. Embo J. 1984;3:1–10.
   PubMed Web of Science ®Google Scholar
• Lown JA, Barr AL, Kelly A. Auto anti-M antibody following renal transplantation. Vox Sang. 1980;38:301–304.
   Web of Science ®Google Scholar
• Faure J, Lachenal G, Court M, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci. 2006;31:642–648.
   PubMed Web of Science ®Google Scholar
• Mustapic M, Eitan E, Werner JK Jr., et al. Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes. Front Neurosci. 2017;11:278.
   PubMed Web of Science ®Google Scholar
• Lazar I, Clement E, Ducoux-Petit M, et al. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines. Pigment Cell Melanoma Res. 2015;28:464–475.
   PubMed Web of Science ®Google Scholar
• Liang B, Peng P, Chen S, et al. Characterization and proteomic analysis of ovarian cancer-derived exosomes. J Proteomics. 2013;80:171–182.
   PubMed Web of Science ®Google Scholar
• Lamontagne-Proulx J, St-Amour I, Labib R, et al. Portrait of blood-derived extracellular vesicles in patients with Parkinson’s disease. Neurobiol Dis. 2019;124:163–175.
   Web of Science ®Google Scholar
• Reid W, Sadowska M, Denaro F, et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A. 2001;98:9271–9276.
   PubMed Web of Science ®Google Scholar
• Peng J, Vigorito M, Liu X, et al. The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol. 2010;218:94–101.
   PubMed Web of Science ®Google Scholar
• Vigorito M, Connaghan KP, Chang SL. The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun. 2015;48:336–349.
   PubMed Web of Science ®Google Scholar
• Sundermann EE, Heaton RK, Pasipanodya E, et al. Sex differences in HIV-associated cognitive impairment. AIDS. 2018;32:2719–2726.
   Web of Science ®Google Scholar
• Sampey GC, Meyering SS, Zadeh MA, et al. Exosomes and their role in CNS viral infections. J Neurovirol. 2014;20:199–208.
   Web of Science ®Google Scholar
• Hurwitz SN, Sun L, Cole KY, et al. An optimized method for enrichment of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer’s disease. J Neurosci Methods. 2018;307:210–220.
   Web of Science ®Google Scholar
• Coumans FAW, Brisson AR, Buzas EI, et al. Methodological guidelines to study extracellular vesicles. Circ Res. 2017;120:1632–1648.
   PubMed Web of Science ®Google Scholar
• Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.
   PubMed Web of Science ®Google Scholar
• Narayanan A, Iordanskiy S, Das R, et al. Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA. J Biol Chem. 2013;288:20014–20033.
   PubMed Web of Science ®Google Scholar
• Iwai K, Minamisawa T, Suga K, et al. Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. J Extracell Vesicles. 2016;5:30829.
   PubMed Web of Science ®Google Scholar
• Fiandaca MS, Kapogiannis D, Mapstone M, et al. Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015;11:600–607 e601.
   PubMed Web of Science ®Google Scholar
• Sun B, Dalvi P, Abadjian L, et al. Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV. AIDS. 2017;31:F9–F17.
   PubMed Web of Science ®Google Scholar
• DeMarino C, Pleet ML, Cowen M, et al. Antiretroviral drugs alter the content of extracellular vesicles from HIV-1-infected cells. Sci Rep. 2018;8:7653.
   Google Scholar
• Kakad PP, Penserga T, Davis BP, et al. An ankyrin-binding motif regulates nuclear levels of L1-type neuroglian and expression of the oncogene Myc in Drosophila neurons. J Biol Chem. 2018;293:17442–17453.
   Web of Science ®Google Scholar
• Mechtersheimer S, Gutwein P, Agmon-Levin N, et al. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol. 2001;155:661–673.
   PubMed Web of Science ®Google Scholar
• Gorantla S, Poluektova L, Gendelman HE. Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci. 2012;35:197–208.
   PubMed Web of Science ®Google Scholar
• Joseph J. Optimizing animal models for HIV-associated CNS dysfunction and CNS reservoir research. J Neurovirol. 2018;24:137–140.
   Web of Science ®Google Scholar
• Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med. 2011;19:137–142.
   PubMedGoogle Scholar
• Dahl V, Peterson J, Fuchs D, et al. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS. 2014;28:2251–2258.
   PubMed Web of Science ®Google Scholar
• Rowson SA, Harrell CS, Bekhbat M, et al. Neuroinflammation and behavior in HIV-1 transgenic rats exposed to chronic adolescent stress. Front Psychiatry. 2016;7:102.
   Web of Science ®Google Scholar
• Chettimada S, Lorenz DR, Misra V, et al. Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy. Sci Rep. 2018;8:7227.
   PubMed Web of Science ®Google Scholar
• Van Deun J, Mestdagh P, Sormunen R, et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles. 2014;3:24858–24871.
   Google Scholar
• Guix FX, Corbett GT, Cha DJ, et al. Detection of aggregation-competent tau in neuron-derived extracellular vesicles. Int J Mol Sci. 2018;19:663–685.
   Web of Science ®Google Scholar
• Lutz D, Wolters-Eisfeld G, Joshi G, et al. Generation and nuclear translocation of sumoylated transmembrane fragment of cell adhesion molecule L1. J Biol Chem. 2012;287:17161–17175.
   Web of Science ®Google Scholar
• Kiefel H, Bondong S, Hazin J, et al. L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr. 2012;6:374–384.
   PubMed Web of Science ®Google Scholar
• Hooper NM, Karran EH, Turner AJ. Membrane protein secretases. Biochem J. 1997;321(Pt 2):265–279.
   PubMedGoogle Scholar